Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jneb.2011.03.005 | DOI Listing |
J Pharm Pharm Sci
June 2024
William Carey University School of Pharmacy Department of Pharmaceutical Sciences, Biloxi, MS, United States.
Purpose: This study evaluated the safety and efficacy of two insulin regimens for inpatient hyperglycemia management: combination short-plus long-acting insulin (basal-bolus insulin regimen, BBIR) vs. short-acting insulin only (correctional insulin only regimen, CIOR).
Methods: Chart reviews identified noncritically ill patients with pre-existing type 2 diabetes mellitus receiving insulin injections.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!